News | February 04, 2013

Elekta Supports First Patient Treated with Carbon Ion Therapy at Italian Cancer Center

Elekta Mosaiq Radiation Oncology Information System Centro Nazionale di Adrotera

February 4, 2013 — The need for flawless coordination of its carbon ion treatments led officials at the CNAO Foundation (Centro Nazionale di Adroterapia Oncologica) to choose Elekta’s Mosaiq Oncology Information Management System. On Nov. 13, the CNAO Foundation became the world’s first center to use Mosaiq to guide a cancer patient’s carbon ion therapy. CNAO — which made news last year when it treated its first patient with proton therapy — is now nearing completion of its National Center of Oncological Hadrontherapy.

Dr. Sandro Rossi, general manager and technical director of the CNAO Foundation, says that after an initial start up phase the center will be running double shifts, treating 150 to 200 patients a month with both proton therapy and carbon ion therapy.

Using Mosaiq, which incorporates its record and verify module for particle therapy accelerator technology, CNAO will store and retrieve data related to particle therapy treatment and follow-up care for patients, as well as the center’s cancer care and treatment research. “In our daily routine, Mosaiq has helped us schedule procedures and facilitate more efficient workflow for our clinical and scientific research activities,” Rossi explains.

A specific advantage of carbon ion treatments is the possibility to prescribe and report physical and biological doses differently than other therapies, and the necessity to schedule pre-positioning procedures to optimize patient throughput. Elekta has demonstrated its commitment to work with CNAO to extend Mosaiq capabilities to operate within this environment. Combined with the flexibility that Mosaiq demonstrates, this was a strong selling point for CNAO, according to Rossi.

“A very compelling Mosaiq feature is the possibility to integrate, expand and fine tune the solution to include the different procedures that will be developed during the working life of a facility like CNAO,” he says. “The use of Mosaiq also will lead to a high level of optimization of staffing activities.”

“Embracing the ability to extend our particle therapy offering to incorporate carbon ions was a first for Elekta and one that we are excited to be undertaking with CNAO,” says Todd Powell, executive vice president, Elekta Software. “Our success in this area will further advance our solution and reinforce our market leadership as a provider of patient management solutions within particle therapy.”

For more information: www.elekta.com

Related Content

Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...